RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
G
ABCA1
ATP binding cassette subfamily A member 1
ISO
mRNA:increased expression:liver (human)
RGD
PMID:28660384
RGD:21203516
NCBI chr11:60,761,669...60,869,753
Ensembl chr11:60,761,655...60,890,496
G
ABCB4
ATP binding cassette subfamily B member 4
disease_progression treatment
ISO
CTD Direct Evidence: marker/mechanism DNA:SNPs, haplotype, diplotype: : rs31658, rs31672,rs1149222(human)
CTD RGD
PMID:18671305 PMID:20040336 PMID:21209952 PMID:30682444
RGD:14694982 RGD:153297773
NCBI chr14:13,542,610...13,614,334
Ensembl chr14:13,548,462...13,614,571
G
ABCC2
ATP binding cassette subfamily C member 2
ISO
CTD Direct Evidence: marker/mechanism protein:decreased expression:liver
CTD RGD
PMID:15542527 PMID:15770136
RGD:14700810
NCBI chr28:12,670,885...12,740,124
Ensembl chr28:12,670,885...12,740,740
G
ABCG2
ATP binding cassette subfamily G member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15542527
NCBI chr32:11,443,778...11,517,674
Ensembl chr32:11,443,780...11,517,674
G
ACE
angiotensin I converting enzyme
ISO
mRNA:increased expression:liver
RGD
PMID:19389807
RGD:2325226
NCBI chr 9:11,497,182...11,516,362
Ensembl chr 9:11,497,182...11,516,358
G
ACE2
angiotensin converting enzyme 2
ISO
mRNA, protein:increased expression:liver
RGD
PMID:17532087
RGD:9685452
NCBI chr X:11,798,839...11,839,591
Ensembl chr X:11,798,839...11,900,594
G
AGT
angiotensinogen
ISO
protein:increased expression:plasma
RGD
PMID:17532087
RGD:9685452
NCBI chr 4:8,681,192...8,694,059
Ensembl chr 4:8,683,798...8,693,880
G
ALB
albumin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30026087
NCBI chr13:62,133,747...62,169,349
Ensembl chr13:62,053,814...62,294,709
G
AQP4
aquaporin 4
ISO
RGD
PMID:20451280
RGD:5148030
NCBI chr 7:61,855,617...61,868,953
Ensembl chr 7:61,855,744...61,865,089
G
B9D2
B9 domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30026087
NCBI chr 1:112,621,832...112,627,726
Ensembl chr 1:112,621,633...112,643,885
G
CCL5
C-C motif chemokine ligand 5
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver:
CTD RGD
PMID:12126966 PMID:15770052
RGD:14995336
NCBI chr 9:37,817,409...37,823,852
Ensembl chr 9:37,817,305...37,823,852
G
CCN2
cellular communication network factor 2
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:19371232
RGD:2314517
NCBI chr 1:25,508,082...25,511,058
Ensembl chr 1:25,507,662...25,510,145
G
CD3D
CD3 delta subunit of T-cell receptor complex
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18422935
NCBI chr 5:15,392,841...15,396,745
Ensembl chr 5:15,389,243...15,396,750
G
CD80
CD80 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21399635
NCBI chr33:23,177,136...23,208,421
Ensembl chr33:23,177,138...23,201,380
G
CDH5
cadherin 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18422935
NCBI chr 5:82,830,505...82,863,931
Ensembl chr 5:82,830,939...82,863,882
G
CDKN1A
cyclin dependent kinase inhibitor 1A
ISO
protein:increased expression:epithelial cell:
RGD
PMID:18456456
RGD:8662434
NCBI chr12:5,746,898...5,755,103
Ensembl chr12:5,745,852...5,892,281
G
CENPB
centromere protein B
ISO
RGD
PMID:8911074
RGD:27226708
NCBI chr24:17,569,440...17,572,311
Ensembl chr24:17,569,663...17,572,127
G
CLEC16A
C-type lectin domain containing 16A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21399635
NCBI chr 6:31,560,940...31,757,100
Ensembl chr 6:31,562,834...31,757,678
G
COL1A1
collagen type I alpha 1 chain
treatment
ISO
RGD
PMID:20056896
RGD:8552731
NCBI chr 9:26,183,852...26,199,927
Ensembl chr 9:26,183,852...26,199,927
G
CPEB1
cytoplasmic polyadenylation element binding protein 1
ISO
protein:increased expression:liver
RGD
PMID:26627607
RGD:11528851
NCBI chr 3:54,405,140...54,499,614
Ensembl chr 3:54,405,717...54,500,221
G
CPEB4
cytoplasmic polyadenylation element binding protein 4
ISO
protein:increased expression:liver
RGD
PMID:26627607
RGD:11528851
NCBI chr 4:38,604,065...38,665,200
Ensembl chr 4:38,607,948...38,664,821
G
CTLA4
cytotoxic T-lymphocyte associated protein 4
susceptibility no_association disease_progression
ISO
autoimmune biliary cirrhosis; DNA:SNP:CDS:49A>G, significant association with G allele (p<0.0002) DNA:SNP:CDS:49A>G(human) DNA:SNP:CDS:60G>A(rs3087243)(human) DNA:SNPs: :rs231775, rs3087243, rs231725 (human)
RGD
PMID:10782900 PMID:16584111 PMID:17482523 PMID:21594562
RGD:14398725 RGD:14398743 RGD:14398744 RGD:2301998
NCBI chr37:12,647,712...12,653,874
Ensembl chr37:12,634,563...12,653,874
G
CXCL10
C-X-C motif chemokine ligand 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18422935
NCBI chr32:598,406...599,925
Ensembl chr32:597,987...599,979
G
CXCL8
C-X-C motif chemokine ligand 8
ISO
mRNA:increased expression:liver (human)
RGD
PMID:21731723
RGD:26884357
NCBI chr13:62,435,035...62,438,354
Ensembl chr13:62,434,422...62,438,354
G
CXCR5
C-X-C motif chemokine receptor 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21399635
NCBI chr 5:14,921,447...14,932,937
Ensembl chr 5:14,923,089...14,932,762
G
CYGB
cytoglobin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30026087
NCBI chr 9:4,191,114...4,201,438
Ensembl chr 9:4,184,959...4,200,164
G
DAG1
dystroglycan 1
ISO
mRNA:increased expression:liver
RGD
PMID:12177244
RGD:2314895
NCBI chr20:39,707,672...39,779,094
Ensembl chr20:39,708,053...39,778,550
G
DENND1B
DENN domain containing 1B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21399635
NCBI chr 7:5,008,249...5,267,392
Ensembl chr 7:4,999,430...5,262,630
G
DNASE1
deoxyribonuclease 1
ISO
protein:decreased activity:serum (human)
RGD
PMID:28263100
RGD:38500241
NCBI chr 6:37,596,735...37,599,953
Ensembl chr 6:37,595,911...37,599,827
G
ENTPD2
ectonucleoside triphosphate diphosphohydrolase 2
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:15651265
RGD:9685530
NCBI chr 9:48,589,408...48,594,852
Ensembl chr 9:48,570,891...48,594,452
G
FAS
Fas cell surface death receptor
ISO
protein:increased expression:lymphocyte:
RGD
PMID:26429926
RGD:14700711
NCBI chr26:38,738,811...38,763,298
Ensembl chr26:38,737,611...38,763,321
G
FOXP3
forkhead box P3
ISO
mRNA:increased expression:liver
RGD
PMID:17158635
RGD:38501106
NCBI chr X:42,331,229...42,362,841
Ensembl chr X:42,344,108...42,350,758
G
GCH1
GTP cyclohydrolase 1
treatment
ISO
RGD
PMID:20132096
RGD:329970291
NCBI chr 8:30,733,422...30,784,067
Ensembl chr 8:30,732,608...30,784,156
G
HAMP
hepcidin antimicrobial peptide
treatment
ISO
mRNA:decreased expression:liver
RGD
PMID:19652645 PMID:23704825
RGD:11041639 RGD:11041732
NCBI chr 1:117,305,531...117,306,587
Ensembl chr 1:117,305,411...117,306,619
G
HHIP
hedgehog interacting protein
ISO
mRNA:decreased expression:
RGD
PMID:18375471
RGD:11552599
NCBI chr15:43,432,464...43,525,973
Ensembl chr15:43,431,650...43,520,861
G
HIF1A
hypoxia inducible factor 1 subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22271822
NCBI chr 8:36,614,045...36,656,692
Ensembl chr 8:36,614,045...36,656,692
G
HMOX1
heme oxygenase 1
ISO
mRNA, protein:increased expression:liver, lung
RGD
PMID:12114196
RGD:625603
NCBI chr10:28,744,404...28,751,544
Ensembl chr10:28,743,795...28,751,773
G
ICAM1
intercellular adhesion molecule 1
treatment
ISO
associated with Graft vs Host Disease;
RGD
PMID:10051478
RGD:11520783
NCBI chr20:50,818,715...50,827,914
Ensembl chr20:50,818,715...50,827,914
G
ICAM3
intercellular adhesion molecule 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18422935
NCBI chr20:50,777,422...50,783,853
Ensembl chr20:50,777,467...50,783,787
G
IFNG
interferon gamma
ISO
mRNA:increased expression:liver
RGD
PMID:17158635
RGD:38501106
NCBI chr10:10,406,866...10,411,698
Ensembl chr10:10,406,867...10,411,698
G
IGFBP1
insulin like growth factor binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18422935
NCBI chr16:1,037,169...1,040,996
Ensembl chr16:1,037,162...1,167,094
G
IL10
interleukin 10
ISO
mRNA:increased expression:liver
RGD
PMID:17158635
RGD:38501106
NCBI chr 7:5,933,285...5,937,057
Ensembl chr 7:5,933,285...5,937,057
G
IL12A
interleukin 12A
susceptibility treatment
ISO
DNA:SNPs, haplotype: :rs6441286, rs574808(human) DNA:SNP: :rs62270414(human) CTD Direct Evidence: marker/mechanism DNA:SNPs:enhancer:rs4679868, rs6441286, rs666251(human)
RGD CTD
PMID:19458352 PMID:20639880 PMID:23433321 PMID:27175695
RGD:25440489 RGD:25440498 RGD:25440500
NCBI chr34:26,125,529...26,133,546
Ensembl chr34:26,124,770...26,133,550
G
IL12B
interleukin 12B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20639880
NCBI chr 4:51,178,637...51,194,606
Ensembl chr 4:51,183,568...51,193,228
G
IL12RB1
interleukin 12 receptor subunit beta 1
susceptibility
ISO
RNA:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:23910013
RGD:14700865
NCBI chr20:44,885,410...44,908,139
Ensembl chr20:44,885,337...44,904,538
G
IL4
interleukin 4
treatment
ISO
RGD
PMID:20442198
RGD:7829828
NCBI chr11:20,972,693...20,981,539
Ensembl chr11:20,972,690...20,981,534
G
IL7R
interleukin 7 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21399635
NCBI chr 4:72,633,528...72,668,242
Ensembl chr 4:72,636,325...72,668,300
G
JAK2
Janus kinase 2
treatment
ISO
RGD
PMID:24619965
RGD:10403061
NCBI chr 1:93,321,055...93,438,898
Ensembl chr 1:93,142,635...93,435,997
G
KEAP1
kelch like ECH associated protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30026087
NCBI chr20:50,651,070...50,661,178
Ensembl chr20:50,650,711...50,658,496
G
KRT18
keratin 18
severity
ISO
protein:increased expression:serum (human)
RGD
PMID:26110613
RGD:18337483
NCBI chr27:2,189,269...2,193,368
Ensembl chr27:2,189,269...2,193,368
G
KRT7
keratin 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21681009
NCBI chr27:2,812,709...2,827,451
G
LBR
lamin B receptor
ISO
RGD
PMID:8550049
RGD:9588625
NCBI chr 7:39,289,517...39,309,026
Ensembl chr 7:39,288,147...39,307,606
G
LEP
leptin
ISO
protein:decreased expression:serum:
RGD
PMID:16093869
RGD:10411894
NCBI chr14:8,115,396...8,130,946
Ensembl chr14:8,116,122...8,131,395
G
LEPR
leptin receptor
ISO
protein:increased expression:blood serum
RGD
PMID:16093869
RGD:10411894
NCBI chr 5:44,684,118...44,775,626
Ensembl chr 5:44,688,109...44,775,636
G
LOX
lysyl oxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16023247
NCBI chr11:12,023,645...12,040,015
Ensembl chr11:12,027,250...12,039,819
G
LOXL2
lysyl oxidase like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16023247
NCBI chr25:34,095,858...34,186,775
Ensembl chr25:34,126,335...34,185,969
G
MAP3K14
mitogen-activated protein kinase kinase kinase 14
ISO
OMIM:109720 | OMIM:613007 | OMIM:613008 | OMIM:614220 | OMIM:614221
MouseDO
NCBI chr 9:18,255,416...18,302,405
Ensembl chr 9:18,280,198...18,302,401
G
MAPK14
mitogen-activated protein kinase 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30026087
NCBI chr12:5,145,647...5,221,558
Ensembl chr12:5,146,037...5,220,603
G
MAS1
MAS1 proto-oncogene, G protein-coupled receptor
ISO
RGD
PMID:17532087
RGD:9685452
NCBI chr 1:49,090,041...49,105,244
Ensembl chr 1:49,090,041...49,105,244
G
MET
MET proto-oncogene, receptor tyrosine kinase
severity
ISO
RGD
PMID:19208365
RGD:14694826
NCBI chr14:55,599,047...55,711,626
Ensembl chr14:55,598,337...55,724,027
G
MIR21
microRNA mir-21
severity
ISO
RGD
PMID:28886078
RGD:21408577
NCBI chr 9:34,340,550...34,340,609
Ensembl chr 9:34,340,533...34,340,624
G
MIR223
microRNA mir-223
severity
ISO
RGD
PMID:28886078
RGD:21408577
NCBI chr X:50,838,131...50,838,233
Ensembl chr X:50,838,131...50,838,233
G
MMEL1
membrane metalloendopeptidase like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20639879
NCBI chr 5:57,434,880...57,467,973
Ensembl chr 5:57,434,886...57,465,911
G
MMP13
matrix metallopeptidase 13
treatment
ISO
RGD
PMID:20056896
RGD:8552731
NCBI chr 5:28,793,568...28,864,832
Ensembl chr 5:28,850,522...28,864,121
G
MMP2
matrix metallopeptidase 2
treatment
ISO
RGD
PMID:20056896
RGD:8552731
NCBI chr 2:60,471,092...60,492,991
Ensembl chr 2:60,471,257...60,494,113
G
MMP3
matrix metallopeptidase 3 (stromelysin 1, progelatinase)
treatment
ISO
RGD
PMID:20056896
RGD:8552731
NCBI chr 5:28,949,631...28,957,915
Ensembl chr 5:28,949,631...28,958,222
G
MMP9
matrix metallopeptidase 9
treatment
ISO
RGD
PMID:20056896
RGD:8552731
NCBI chr24:33,274,260...33,281,116
Ensembl chr24:33,274,268...33,281,293
G
MUC2
mucin 2, oligomeric mucus/gel-forming
ISO
RGD
PMID:18507686
RGD:2324885
NCBI chr18:45,416,347...45,438,226
G
MYBPC2
myosin binding protein C2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20639880
NCBI chr 1:106,294,360...106,301,700
Ensembl chr 1:106,266,817...106,301,686
G
NFE2L2
NFE2 like bZIP transcription factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30026087
NCBI chr36:20,989,205...21,087,044
Ensembl chr36:20,989,360...21,012,524
G
NFKB1
nuclear factor kappa B subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21399635
NCBI chr32:23,948,598...24,040,704
Ensembl chr32:23,942,954...24,040,703
G
NOS2
nitric oxide synthase 2
ISO
protein:increased expression, increased activity:brain (rat) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:21903766 PMID:30026087
RGD:5509055
NCBI chr 9:42,171,821...42,210,217
Ensembl chr 9:42,171,821...42,208,588
G
NOS3
nitric oxide synthase 3
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20132096 PMID:30026087
RGD:329970291
NCBI chr16:15,054,196...15,072,454
Ensembl chr16:15,011,344...15,072,277
G
NR1H4
nuclear receptor subfamily 1 group H member 4
susceptibility
ISO
mRNA,protein:decreased expression:liver (human)
RGD
PMID:29968724
RGD:14928336
NCBI chr15:39,497,313...39,608,120
Ensembl chr15:39,536,290...39,608,116
G
NR3C1
nuclear receptor subfamily 3 group C member 1
ISO
mRNA:altered expression:leukocyte, mononuclear
RGD
PMID:15635817
RGD:4892607
NCBI chr 2:38,124,568...38,242,510
Ensembl chr 2:38,123,190...38,240,755
G
NSA2
NSA2 ribosome biogenesis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18422935
NCBI chr 2:57,304,160...57,311,836
G
NUP62
nucleoporin 62
severity
ISO
RGD
PMID:12753810
RGD:9831196
NCBI chr 1:106,636,282...106,661,250
G
PDE5A
phosphodiesterase 5A
ISO
RGD
PMID:17610866
RGD:2314466
NCBI chr32:38,272,573...38,407,517
Ensembl chr32:38,244,338...38,407,522
G
PPARGC1A
PPARG coactivator 1 alpha
ISO
mRNA, protein:decreased expression:liver
RGD
NCBI chr 3:85,645,942...86,284,570
Ensembl chr 3:86,016,140...86,281,269
G
RELA
RELA proto-oncogene, NF-kB subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30026087
NCBI chr18:51,550,003...51,558,861
Ensembl chr18:51,550,040...51,558,875
G
REN
renin
ISO
protein:increased activity:plasma (rat)
RGD
PMID:22266601
RGD:6892690
NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012
G
RPS6KB1
ribosomal protein S6 kinase B1
ISO
protein:increased expression, increased phosphorylation:liver
RGD
PMID:15769867
RGD:1642977
NCBI chr 9:34,387,084...34,590,603
Ensembl chr 9:34,387,091...34,425,292
G
SLC4A2
solute carrier family 4 member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18188457
NCBI chr16:15,111,078...15,126,618
Ensembl chr16:15,111,116...15,126,617
G
SLC51A
solute carrier family 51 member A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16423920
NCBI chr33:29,336,000...29,361,782
Ensembl chr33:29,336,552...29,361,738
G
SLC51B
SLC51 subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16423920
NCBI chr30:29,425,489...29,436,204
Ensembl chr30:29,425,860...29,436,073
G
SLCO1C1
solute carrier organic anion transporter family member 1C1
ISO
protein:decreased expression:liver
RGD
PMID:15770136
RGD:14700810
NCBI chr27:26,497,639...26,553,790
Ensembl chr27:26,498,292...26,553,314
G
SOD2
superoxide dismutase 2
ISO
protein:increased expression:serum
RGD
PMID:1682406
RGD:2317411
NCBI chr 1:48,943,472...48,955,158
Ensembl chr 1:48,836,262...48,955,706
G
SPINT1
serine peptidase inhibitor, Kunitz type 1
ISO
mRNA:increased expression:liver:
RGD
PMID:21898507
RGD:10043111
NCBI chr30:7,976,094...7,989,019
Ensembl chr30:7,975,235...7,988,339
G
SPINT2
serine peptidase inhibitor, Kunitz type 2
ISO
mRNA:increased expression:liver:
RGD
PMID:21898507
RGD:10043111
NCBI chr 1:114,699,050...114,727,802
Ensembl chr 1:114,699,241...114,727,763
G
STAT4
signal transducer and activator of transcription 4
susceptibility no_association
ISO
CTD Direct Evidence: marker/mechanism associated with Crohn���s disease; DNA:SNP:intron: (rs7574865) (human) DNA:SNP: intron: (rs7574865) (human) DNA:SNPs:3'utr: (rs7574865, rs8179673, rs10181656) (human) DNA:SNPs, haplotypes:multiple
CTD RGD
PMID:21399635 PMID:24648611 PMID:26084578 PMID:28395724
RGD:25671415 RGD:25671416 RGD:25671421
NCBI chr37:1,566,563...1,685,378
Ensembl chr37:1,566,585...1,829,894
G
TJP2
tight junction protein 2
ISO
ClinVar Annotator: match by term: Primary biliary cholangitis
ClinVar
PMID:25741868 PMID:28492532 PMID:32439973
NCBI chr 1:88,126,134...88,251,018
Ensembl chr 1:88,126,136...88,230,654
G
TLR9
toll like receptor 9
ISO
protein:increased expression:liver, peripheral blood mononuclear cell (human)
RGD
PMID:23026026
RGD:18337477
NCBI chr20:37,529,322...37,547,117
Ensembl chr20:37,542,340...37,547,114 Ensembl chr20:37,542,340...37,547,114
G
TNF
tumor necrosis factor
ISO
protein:increased expression:serum (human) mRNA:increased expression:liver
RGD
PMID:9047083 PMID:17158635
RGD:14995307 RGD:38501106
NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
G
TNFRSF1A
TNF receptor superfamily member 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21399635
NCBI chr27:38,641,837...38,654,693
Ensembl chr27:38,638,753...38,700,282
G
TYK2
tyrosine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22961000
NCBI chr20:50,747,145...50,770,008
Ensembl chr20:50,748,329...50,769,216
G
UBD
ubiquitin D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18422935
NCBI chr35:26,426,919...26,436,189
G
UTP4
UTP4 small subunit processome component
ISO
North American Indian childhood cirrhosis, OMIM:604901, R565W
RGD
PMID:12417987
RGD:1600653
NCBI chr 5:80,474,219...80,508,953
Ensembl chr 5:80,406,084...80,508,981
G
VDR
vitamin D receptor
susceptibility
ISO
DNA:polymorphism: : DNA:SNP: :
RGD
PMID:15683428 PMID:19376604
RGD:14401750 RGD:14402024
NCBI chr27:6,852,915...6,909,466
Ensembl chr27:6,852,723...6,909,470
G
VEGFA
vascular endothelial growth factor A
ISO
protein:increased expression:liver protein:increased expression:plasma:
RGD
PMID:26615570 PMID:26627607
RGD:11528851 RGD:11538286
NCBI chr12:12,209,032...12,224,978
Ensembl chr12:12,208,231...12,224,965
G
ZC3H12A
zinc finger CCCH-type containing 12A
ISO
OMIM:109720 | OMIM:613007 | OMIM:613008 | OMIM:614220 | OMIM:614221
MouseDO
NCBI chr15:4,972,369...4,984,218
Ensembl chr15:4,972,956...4,980,371
G
UTP4
UTP4 small subunit processome component
ISO
ClinVar Annotator: match by term: Hereditary North American Indian childhood cirrhosis
ClinVar
PMID:9536098 PMID:12417987 PMID:16225863 PMID:17576681 PMID:19732766 PMID:20385600 PMID:22916032 PMID:24123366 PMID:25741868 PMID:27535533 PMID:28492532 More...
NCBI chr 5:80,474,219...80,508,953
Ensembl chr 5:80,406,084...80,508,981
G
IL12RB2
interleukin 12 receptor subunit beta 2
ISO
ClinVar Annotator: match by term: IL12RB2-related condition
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 5:43,197,034...43,269,571
Ensembl chr 5:43,197,034...43,257,594
G
LBR
lamin B receptor
ISO
ClinVar Annotator: match by term: PRIMARY BILIARY CIRRHOSIS, SCLERODERMA, RAYNAUD DISEASE, AND TELANGIECTASIA | ClinVar Annotator: match by term: Reynolds syndrome
OMIM ClinVar
PMID:18382993 PMID:20522425 PMID:24033266 PMID:25348816 PMID:25741868 PMID:26467025 PMID:28492532 PMID:32827848 More...
NCBI chr 7:39,289,517...39,309,026
Ensembl chr 7:39,288,147...39,307,606
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all